BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 12112198)

  • 1. Case-control study of estrogen receptor gene polymorphisms in Parkinson's disease.
    Maraganore DM; Farrer MJ; McDonnell SK; Elbaz A; Schaid DJ; Hardy JA; Rocca WA
    Mov Disord; 2002 May; 17(3):509-12. PubMed ID: 12112198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the estrogen receptor beta gene and age of onset of Parkinson's disease.
    Westberg L; Håkansson A; Melke J; Shahabi HN; Nilsson S; Buervenich S; Carmine A; Ahlberg J; Grundell MB; Schulhof B; Klingborg K; Holmberg B; Sydow O; Olson L; Johnels EB; Eriksson E; Nissbrandt H
    Psychoneuroendocrinology; 2004 Sep; 29(8):993-8. PubMed ID: 15219649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease.
    Goudreau JL; Maraganore DM; Farrer MJ; Lesnick TG; Singleton AB; Bower JH; Hardy JA; Rocca WA
    Mov Disord; 2002 Nov; 17(6):1305-11. PubMed ID: 12465073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system.
    Goldman JG; Goetz CG; Berry-Kravis E; Leurgans S; Zhou L
    Arch Neurol; 2004 Aug; 61(8):1280-4. PubMed ID: 15313848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.
    Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Kashiwagi B; Nishii M; Ohtake N; Nakata S; Ito K; Yamanaka H
    Cancer; 2003 Oct; 98(7):1411-6. PubMed ID: 14508827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case-only study of interactions between genetic polymorphisms of GSTM1, P1, T1 and Z1 and smoking in Parkinson's disease.
    Deng Y; Newman B; Dunne MP; Silburn PA; Mellick GD
    Neurosci Lett; 2004 Aug; 366(3):326-31. PubMed ID: 15288444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of monocyte chemoattractant protein 1 gene polymorphism on age at onset of sporadic Parkinson's disease.
    Nishimura M; Kuno S; Mizuta I; Ohta M; Maruyama H; Kaji R; Kawakami H
    Mov Disord; 2003 Aug; 18(8):953-5. PubMed ID: 12889089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association between estrogen receptor beta gene polymorphisms and Parkinson disease].
    Chen RJ; Zhang BS; Wang SM
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1185-8. PubMed ID: 18844113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The alpha-synuclein gene microsatellite polymorphism and late-onset sporadic Parkinson's disease susceptibility].
    Zhao XP; Zheng HM; Xie HJ; Ding SJ; Ren DM
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):339-41. PubMed ID: 15300629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Joint effects of the CYP1A1 MspI, ERalpha PvuII, and ERalpha XbaI polymorphisms on the risk of breast cancer: results from a population-based case-control study in Shanghai, China.
    Shen Y; Li DK; Wu J; Zhang Z; Gao E
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):342-7. PubMed ID: 16492926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of evidence for a genetic association between FGF20 and Parkinson's disease in Finnish and Greek patients.
    Clarimon J; Xiromerisiou G; Eerola J; Gourbali V; Hellström O; Dardiotis E; Peuralinna T; Papadimitriou A; Hadjigeorgiou GM; Tienari PJ; Singleton AB
    BMC Neurol; 2005 Jun; 5():11. PubMed ID: 15967032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms in the estrogen receptor alpha gene and risk of breast cancer: results from the Shanghai Breast Cancer Study.
    Cai Q; Shu XO; Jin F; Dai Q; Wen W; Cheng JR; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):853-9. PubMed ID: 14504194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association of estrogen receptor gene polymorphism with cerebral infarction, a case-control study].
    Zhang Y; Xie R; Wang Y; Chen D; Wang G; Xu X
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1443-6. PubMed ID: 12509901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraoxonase 1 (PON1) gene polymorphisms and Parkinson's disease in a Finnish population.
    Clarimon J; Eerola J; Hellström O; Tienari PJ; Singleton A
    Neurosci Lett; 2004 Sep; 367(2):168-70. PubMed ID: 15331145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1).
    Barrero FJ; Ampuero I; Morales B; Vives F; de Dios Luna Del Castillo J; Hoenicka J; García Yébenes J
    Pharmacogenomics J; 2005; 5(2):135-41. PubMed ID: 15668727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.
    Bialecka M; Kurzawski M; Klodowska-Duda G; Opala G; Tan EK; Drozdzik M
    Pharmacogenet Genomics; 2008 Sep; 18(9):815-21. PubMed ID: 18698234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of tau gene polymorphism with Parkinson's disease.
    Zappia M; Annesi G; Nicoletti G; Serra P; Arabia G; Pugliese P; Messina D; Caracciolo M; Romeo N; Annesi F; Pasqua AA; Spadafora P; Civitelli D; Romeo N; Epifanio A; Morgante L; Quattrone A
    Neurol Sci; 2003 Oct; 24(3):223-4. PubMed ID: 14600827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a risk haplotype of the alpha-synuclein gene in Japanese with sporadic Parkinson's disease.
    Kobayashi H; Ujike H; Hasegawa J; Yamamoto M; Kanzaki A; Sora I
    Mov Disord; 2006 Dec; 21(12):2157-64. PubMed ID: 17078049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between family history of Parkinson's disease and dementia and risk of dementia in Parkinson's disease: A community-based, longitudinal study.
    Kurz MW; Larsen JP; Kvaloy JT; Aarsland D
    Mov Disord; 2006 Dec; 21(12):2170-4. PubMed ID: 17029273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association between the interleukin-1 alpha (-889) polymorphism and early-onset Parkinson's disease.
    Möller JC; Depboylu C; Kölsch H; Lohmüller F; Bandmann O; Gocke P; Du Y; Paus S; Wüllner U; Gasser T; Oertel WH; Klockgether T; Dodel RC
    Neurosci Lett; 2004 Apr; 359(3):195-7. PubMed ID: 15050696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.